Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/43159
Title: Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial
Authors: MEEKERS, Evelyne 
DAUW, Jeroen 
MARTENS, Pieter 
Dhont, S
Verbrugge, FH
NIJST, Petra 
ter Maaten, JM
Damman, K
Mebazaa, A
Filippatos, G
Ruschitzka, F
Tang, WHW
Dupont, M
MULLENS, Wilfried 
Issue Date: 2023
Publisher: OXFORD UNIV PRESS
Source: EUROPEAN HEART JOURNAL, 44 (37) , p. 3672 -3682
Abstract: In the ADVOR trial, acetazolamide improved decongestion in acute decompensated heart failure (ADHF). Whether the beneficial effects of acetazolamide are consistent across the entire range of renal function remains unclear.
Keywords: Acute heart failure;acetazolamide;decongestion;kidney function;worsening renal function
Document URI: http://hdl.handle.net/1942/43159
ISSN: 0195-668X
e-ISSN: 1522-9645
DOI: 10.1093/eurheartj/ehad557
ISI #: 001062835800001
Rights: The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Category: A1
Type: Journal Contribution
Validations: ecoom 2024
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Renal function and decongestion with acetazolamide in acute decompensated heart failure_ the ADVOR trial.pdfPublished version815.27 kBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.